JP2016521683A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016521683A5 JP2016521683A5 JP2016514523A JP2016514523A JP2016521683A5 JP 2016521683 A5 JP2016521683 A5 JP 2016521683A5 JP 2016514523 A JP2016514523 A JP 2016514523A JP 2016514523 A JP2016514523 A JP 2016514523A JP 2016521683 A5 JP2016521683 A5 JP 2016521683A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- group
- fragment
- hydroxytryptophan
- acetic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361827506P | 2013-05-24 | 2013-05-24 | |
| US61/827,506 | 2013-05-24 | ||
| PCT/IB2014/061634 WO2014188377A2 (en) | 2013-05-24 | 2014-05-22 | Pathway specific assays for predicting irritable bowel syndrome diagnosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019075081A Division JP2019151637A (ja) | 2013-05-24 | 2019-04-10 | 過敏性腸症候群の診断を予測するための経路特異的なアッセイ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016521683A JP2016521683A (ja) | 2016-07-25 |
| JP2016521683A5 true JP2016521683A5 (https=) | 2017-06-29 |
Family
ID=50884973
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016514524A Pending JP2016520199A (ja) | 2013-05-24 | 2014-05-22 | 過敏性腸症候群を診断するための経路特異的マーカー |
| JP2016514523A Pending JP2016521683A (ja) | 2013-05-24 | 2014-05-22 | 過敏性腸症候群の診断を予測するための経路特異的なアッセイ |
| JP2019075081A Pending JP2019151637A (ja) | 2013-05-24 | 2019-04-10 | 過敏性腸症候群の診断を予測するための経路特異的なアッセイ |
| JP2019104805A Pending JP2019194600A (ja) | 2013-05-24 | 2019-06-04 | 過敏性腸症候群を診断するための経路特異的マーカー |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016514524A Pending JP2016520199A (ja) | 2013-05-24 | 2014-05-22 | 過敏性腸症候群を診断するための経路特異的マーカー |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019075081A Pending JP2019151637A (ja) | 2013-05-24 | 2019-04-10 | 過敏性腸症候群の診断を予測するための経路特異的なアッセイ |
| JP2019104805A Pending JP2019194600A (ja) | 2013-05-24 | 2019-06-04 | 過敏性腸症候群を診断するための経路特異的マーカー |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US9891235B2 (https=) |
| EP (2) | EP3004892B1 (https=) |
| JP (4) | JP2016520199A (https=) |
| KR (2) | KR20160010621A (https=) |
| CN (2) | CN105579852B (https=) |
| AU (3) | AU2014269961A1 (https=) |
| BR (2) | BR112015029318A2 (https=) |
| CA (2) | CA2913108A1 (https=) |
| HK (1) | HK1223361A1 (https=) |
| IL (2) | IL242595B (https=) |
| MX (1) | MX367046B (https=) |
| RU (2) | RU2015155552A (https=) |
| SG (2) | SG11201509371XA (https=) |
| WO (2) | WO2014188377A2 (https=) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201509371XA (en) * | 2013-05-24 | 2015-12-30 | Nestec Sa | Pathway specific markers for diagnosing irritable bowel syndrome |
| AU2014284047B2 (en) | 2013-06-21 | 2018-11-22 | Ondek Pty Ltd | Immunotherapy composition and use thereof |
| AU2015257589A1 (en) * | 2014-05-09 | 2016-11-24 | Nogra Pharma Limited | Methods for treating inflammatory bowel disease |
| KR102546748B1 (ko) | 2014-11-19 | 2023-06-22 | 엔제트피 유케이 리미티드 | 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 6α-알킬-3,7-다이온 스테로이드 |
| CN107207559B (zh) | 2014-11-19 | 2019-10-25 | Nzp英国有限公司 | 作为制备类固醇fxr调节剂的中间体的6-烷基-7-羟基-4-烯-3-酮类固醇 |
| SG11201703729RA (en) | 2014-11-19 | 2017-06-29 | Nestec Sa | Antibodies against serotonin, tryptophan and kynurenine metabolites and uses thereof |
| EA033445B1 (ru) | 2014-11-19 | 2019-10-31 | Nzp Uk Ltd | 5-бета-6-алкил-7-гидрокси-3-оновые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr |
| KR102527821B1 (ko) | 2014-11-19 | 2023-05-02 | 엔제트피 유케이 리미티드 | 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 6α-알킬-6,7-다이온 스테로이드 |
| CA2969326A1 (en) * | 2014-12-02 | 2016-06-09 | Nestec S.A. | Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease |
| CN105987995A (zh) * | 2015-02-04 | 2016-10-05 | 东莞博捷生物科技有限公司 | 一种检测人抗酿酒酵母IgG类抗体的酶联免疫试剂盒 |
| CN105987996A (zh) * | 2015-02-09 | 2016-10-05 | 东莞博捷生物科技有限公司 | 一种检测人抗酿酒酵母IgA类抗体的酶联免疫试剂盒 |
| CN105061305A (zh) * | 2015-08-31 | 2015-11-18 | 河南师范大学 | 一步合成3-甲基-2-吡啶甲酸甲酯的方法 |
| GB201608777D0 (en) | 2016-05-18 | 2016-06-29 | Dextra Lab Ltd | Compounds |
| CN106399344B (zh) * | 2016-06-01 | 2021-01-01 | 上海领潮生物新材料有限公司 | 一种vin-cdtb融合蛋白的制备方法 |
| WO2018011691A1 (en) * | 2016-07-12 | 2018-01-18 | Nestec S.A. | Competitive immunoassay methods |
| CN106188191A (zh) * | 2016-07-13 | 2016-12-07 | 西安电子科技大学 | 基于gsh响应的诊治一体化有机分子探针及其制备方法 |
| CA3036702A1 (en) * | 2016-09-15 | 2018-03-22 | Sun Genomics Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| US10428370B2 (en) | 2016-09-15 | 2019-10-01 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| US11959125B2 (en) | 2016-09-15 | 2024-04-16 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| US10610104B2 (en) | 2016-12-07 | 2020-04-07 | Progenity, Inc. | Gastrointestinal tract detection methods, devices and systems |
| EP3554346B1 (en) | 2016-12-14 | 2024-01-31 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with an immunosuppressant |
| WO2018112232A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor released using an ingestible device |
| BR112019012071A2 (pt) | 2016-12-14 | 2019-11-12 | Progenity Inc | tratamento de uma doença do trato gastrointestinal com um inibidor de integrina |
| CA3045310A1 (en) | 2016-12-14 | 2018-06-21 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
| EP3554342B1 (en) | 2016-12-14 | 2024-07-24 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a tnf inhibitor |
| WO2018112256A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an il-1 inhibitor |
| EP3554485B9 (en) | 2016-12-14 | 2023-09-27 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices |
| US11978543B2 (en) | 2016-12-14 | 2024-05-07 | Astarte Medical Partners Inc. | System and methods for developing and using a microbiome-based action component |
| US11134889B2 (en) | 2016-12-14 | 2021-10-05 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a SMAD7 inhibitor |
| EP3554362A4 (en) * | 2016-12-14 | 2020-08-12 | Warren, Tracy | SYSTEM AND METHODS FOR DEVELOPING AND USING A MICROBIOME-BASED ACTION COMPONENT FOR PATIENT HEALTH |
| WO2018112237A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an il-6r inhibitor |
| CA3046019A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a tlr modulator |
| AU2018244922A1 (en) | 2017-03-30 | 2019-09-12 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with live biotherapeutics |
| EP3600414A1 (en) | 2017-03-30 | 2020-02-05 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with il-10 or an il-10 agonist |
| WO2018183932A1 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor |
| US20210138213A1 (en) | 2017-03-30 | 2021-05-13 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
| EP3600249A1 (en) | 2017-03-30 | 2020-02-05 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a chst15 inhibitor |
| US20200306516A1 (en) | 2017-08-14 | 2020-10-01 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with glatiramer or a pharmaceutically acceptable salt thereof |
| US12582809B2 (en) | 2018-01-26 | 2026-03-24 | Bt Bidco, Inc. | Treatment of a disease of the gastrointestinal tract with a PDE4 inhibitor |
| ES3056147T3 (en) * | 2018-02-09 | 2026-02-18 | Metabolomic Diagnostics Ltd | A system and method of generating a model to detect, or predict the risk of, an outcome |
| WO2019181830A1 (ja) * | 2018-03-19 | 2019-09-26 | 富士フイルム和光純薬株式会社 | 精神疾患の判定方法 |
| US12461111B2 (en) * | 2018-04-24 | 2025-11-04 | Universiteit Gent | Intestinal and fecal biomarkers for intestinal health of poultry |
| AU2019278927A1 (en) | 2018-06-01 | 2020-12-24 | Bt Bidco, Inc. | Devices and systems for gastrointestinal microbiome detection and manipulation |
| KR20210018823A (ko) * | 2018-06-07 | 2021-02-18 | 4디 파마 피엘씨 | Ibs 환자 계층화 방법 |
| CN110607335B (zh) * | 2018-06-14 | 2021-08-03 | 中国科学院微生物研究所 | 一种烟酰胺腺嘌呤二核苷酸类化合物生物合成方法 |
| CN109324132A (zh) * | 2018-10-31 | 2019-02-12 | 杭州佰辰医学检验所有限公司 | 高通量检测色氨酸及其代谢产物的试剂盒及其应用 |
| US11488699B1 (en) | 2018-12-09 | 2022-11-01 | Cerner Innovation, Inc. | Microbiota activity sensor and decision support tool |
| US11842795B1 (en) * | 2018-12-17 | 2023-12-12 | Cerner Innovation, Inc. | Irritable bowel syndrome diagnostic sensor and decision support tool |
| FR3094492A1 (fr) * | 2019-04-01 | 2020-10-02 | Polyneuros | Procédé de détection ou de suivi de l’évolution d’une maladie chronique dégénérative par dosage immunologique |
| CN114127317A (zh) * | 2019-04-03 | 2022-03-01 | 4D制药科克有限公司 | 诊断疾病的方法 |
| WO2020213732A1 (ja) * | 2019-04-18 | 2020-10-22 | 株式会社サイキンソー | 過敏性腸症候群の検査方法 |
| US11884958B2 (en) * | 2019-04-30 | 2024-01-30 | Mayo Foundation For Medical Education And Research | Assessing and treating functional gastrointestinal disorders |
| JP2022533956A (ja) | 2019-05-14 | 2022-07-27 | プロメテウス バイオサイエンシーズ，インク． | Ｔｌ１ａ患者を選択する方法、システム、およびデバイス |
| WO2020232262A1 (en) * | 2019-05-16 | 2020-11-19 | Procisedx Inc. | Assay detection methods for vcam-1 and calprotectin |
| CN111351870A (zh) * | 2019-12-03 | 2020-06-30 | 康美华大基因技术有限公司 | 一种肠易激综合征血清代谢标记物组合及其诊断试剂盒 |
| US20230074127A1 (en) | 2020-01-27 | 2023-03-09 | Immundiagnostik Ag | Test and in vitro diagnosis of irritable bowel syndrome |
| WO2021152586A1 (en) * | 2020-01-30 | 2021-08-05 | Yeda Research And Development Co. Ltd. | Methods of analyzing microbiome, immunoglobulin profile and physiological state |
| EP3913371A1 (en) | 2020-05-18 | 2021-11-24 | Neuroimmun GmbH | Method and kit for diagnosting irritable bowel syndrome and for its relief through dietary interventions |
| KR102478205B1 (ko) * | 2020-09-24 | 2022-12-15 | 경희대학교 산학협력단 | 크론병 환자에서 상부위장관 침범 진단을 위한 정보 제공 방법 |
| CN114755313B (zh) * | 2021-01-08 | 2024-08-30 | 复旦大学附属华山医院 | 包含尿液nad+代谢物的急性肾损伤标志物 |
| CN115724779B (zh) * | 2021-09-01 | 2024-03-29 | 四川大学 | 酰胺烷二硫化合物、其制备方法和用途 |
| EP4452939A4 (en) * | 2021-12-24 | 2025-12-10 | Kuleon Llc | SEROTONINERGIC COMPOUNDS, POLYPODS, AND PROMEDICINAL PRODIGITS OF SEROTONIN RECEPTOR AGONISTS AND ANTAGONISTS |
| WO2023180899A1 (en) * | 2022-03-21 | 2023-09-28 | Swain Manish Kumar | Device and method for detecting diarrhea |
| CN116381222A (zh) * | 2023-03-23 | 2023-07-04 | 北京巴瑞医疗器械有限公司 | 一种血清素发光免疫检测方法及血清素检测试剂盒 |
| CN116990498B (zh) * | 2023-09-28 | 2024-08-09 | 山东大学齐鲁医院 | 血浆色氨酸代谢物在儿童偏头痛诊断中的应用 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| AU675929B2 (en) | 1992-02-06 | 1997-02-27 | Curis, Inc. | Biosynthetic binding protein for cancer marker |
| EP0656064B1 (en) | 1992-08-17 | 1997-03-05 | Genentech, Inc. | Bispecific immunoadhesins |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US6218129B1 (en) * | 1998-05-15 | 2001-04-17 | Prometheus Laboratories, Inc. | Inflammatory bowel disease first step assay system |
| US6406862B1 (en) | 1998-10-06 | 2002-06-18 | The United States Of America As Represented By The Secretary Of The Army | Dip-stick assay for C-reactive protein |
| AU784812B2 (en) * | 1999-12-15 | 2006-06-29 | Merck Sharp & Dohme Corp. | Lipopeptides as antibacterial agents |
| US6838250B2 (en) | 2000-03-31 | 2005-01-04 | Ortho-Clinical Diagnostics, Inc. | Immunoassay for C-reactive protein |
| DE10121217A1 (de) * | 2001-04-30 | 2002-10-31 | Merck Patent Gmbh | 6H-Oxazolo[4,5-e]indol-Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden |
| CA2549971A1 (en) | 2003-11-03 | 2005-05-12 | Duke University | Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
| US20060154276A1 (en) * | 2004-05-13 | 2006-07-13 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| WO2006012472A1 (en) | 2004-07-21 | 2006-02-02 | Qualyst, Inc. | Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation |
| WO2007000046A1 (en) * | 2005-06-27 | 2007-01-04 | Holburn Biomedical Corporation | Methods for diagnosing functional bowel disease |
| US7873479B2 (en) | 2005-12-01 | 2011-01-18 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| US20100094560A1 (en) | 2006-08-15 | 2010-04-15 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| US20080085524A1 (en) | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| US8278057B2 (en) | 2007-09-14 | 2012-10-02 | Nestec S.A. | Addressable antibody arrays and methods of use |
| CA2758531C (en) | 2009-04-14 | 2018-11-13 | Derren Barken | Inflammatory bowel disease prognostics |
| US20120171672A1 (en) | 2009-04-14 | 2012-07-05 | Prometheus Laboratories Inc. | Inflammatory bowel disease prognostics |
| WO2010151699A1 (en) | 2009-06-25 | 2010-12-29 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| PH12012500850A1 (en) * | 2009-10-30 | 2013-01-07 | Prometheus Laboratories Inc | Methods for diagnosing irritable bowel syndrome |
| BR112012012513A2 (pt) * | 2009-11-25 | 2017-01-10 | Prometheus Lab Inc | método para diagnosticar síndrome do intestino irritável em um paciente, método para monitorar a progressão ou regressão da síndrome do intestino irritável em um paciente, e para designar uma terapia contra síndrome do intestino irritável a um paciente em necessidade do mesmo |
| US8445215B1 (en) * | 2010-07-23 | 2013-05-21 | Nestec S.A. | Assays and methods for the detection of Crohn's disease |
| EP2710383B1 (en) * | 2011-05-16 | 2017-01-11 | The University of Newcastle | Performance of a biomarker panel for irritable bowel syndrome |
| SG11201401536QA (en) * | 2011-10-21 | 2014-05-29 | Nestec Sa | Methods for improving inflammatory bowel disease diagnosis |
| CA2886991A1 (en) * | 2012-10-05 | 2014-04-10 | Nestec S.A. | Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs |
| SG11201509371XA (en) * | 2013-05-24 | 2015-12-30 | Nestec Sa | Pathway specific markers for diagnosing irritable bowel syndrome |
| TWI853985B (zh) * | 2013-12-04 | 2024-09-01 | 日商中外製藥股份有限公司 | 因應化合物濃度使抗原結合能力變化的抗原結合分子及其資料庫 |
-
2014
- 2014-05-22 SG SG11201509371XA patent/SG11201509371XA/en unknown
- 2014-05-22 MX MX2015016196A patent/MX367046B/es active IP Right Grant
- 2014-05-22 AU AU2014269961A patent/AU2014269961A1/en not_active Abandoned
- 2014-05-22 CA CA2913108A patent/CA2913108A1/en not_active Abandoned
- 2014-05-22 EP EP14728346.9A patent/EP3004892B1/en not_active Not-in-force
- 2014-05-22 JP JP2016514524A patent/JP2016520199A/ja active Pending
- 2014-05-22 WO PCT/IB2014/061634 patent/WO2014188377A2/en not_active Ceased
- 2014-05-22 HK HK16111564.5A patent/HK1223361A1/zh unknown
- 2014-05-22 RU RU2015155552A patent/RU2015155552A/ru unknown
- 2014-05-22 BR BR112015029318A patent/BR112015029318A2/pt not_active Application Discontinuation
- 2014-05-22 CA CA2912993A patent/CA2912993A1/en not_active Abandoned
- 2014-05-22 BR BR112015029320A patent/BR112015029320A8/pt not_active Application Discontinuation
- 2014-05-22 SG SG11201509370UA patent/SG11201509370UA/en unknown
- 2014-05-22 EP EP14731062.7A patent/EP3004068A2/en not_active Withdrawn
- 2014-05-22 CN CN201480041527.7A patent/CN105579852B/zh not_active Expired - Fee Related
- 2014-05-22 RU RU2015155590A patent/RU2015155590A/ru not_active Application Discontinuation
- 2014-05-22 CN CN201480041536.6A patent/CN105392780A/zh active Pending
- 2014-05-22 KR KR1020157036482A patent/KR20160010621A/ko not_active Ceased
- 2014-05-22 WO PCT/IB2014/061636 patent/WO2014188378A1/en not_active Ceased
- 2014-05-22 AU AU2014269960A patent/AU2014269960B2/en not_active Ceased
- 2014-05-22 JP JP2016514523A patent/JP2016521683A/ja active Pending
- 2014-05-22 KR KR1020157036487A patent/KR20160013163A/ko not_active Ceased
-
2015
- 2015-11-11 US US14/938,710 patent/US9891235B2/en not_active Expired - Fee Related
- 2015-11-11 US US14/938,729 patent/US9739786B2/en not_active Expired - Fee Related
- 2015-11-15 IL IL242595A patent/IL242595B/en not_active IP Right Cessation
- 2015-11-15 IL IL242597A patent/IL242597B/en not_active IP Right Cessation
-
2017
- 2017-07-11 US US15/646,838 patent/US10036759B2/en active Active
- 2017-12-19 US US15/847,406 patent/US20180136233A1/en not_active Abandoned
-
2018
- 2018-06-29 US US16/024,183 patent/US10338083B2/en active Active
- 2018-08-09 AU AU2018214104A patent/AU2018214104A1/en not_active Abandoned
-
2019
- 2019-04-10 JP JP2019075081A patent/JP2019151637A/ja active Pending
- 2019-06-04 JP JP2019104805A patent/JP2019194600A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016521683A5 (https=) | ||
| RU2015155552A (ru) | Путеспецифические способы прогнозирования диагноза синдрома раздраженного кишечника | |
| JP2017524725A5 (https=) | ||
| JP2021502063A5 (https=) | ||
| ES2581627T3 (es) | Anticuerpos frente a variante truncada CTF-611 de HER2 | |
| JP2018515474A5 (https=) | ||
| JP2016511254A5 (https=) | ||
| AR080291A1 (es) | Anticuerpos antagonistas anti receptor de il-7 y procedimientos | |
| JP2019523651A5 (https=) | ||
| EA201490677A1 (ru) | Связывающие антиген cd27l белки | |
| WO2012059598A3 (en) | Methods of treating rheumatoid arthritis using il-17 antagonists | |
| EA201001139A1 (ru) | УЛУЧШЕННЫЕ АНТИТЕЛА АНТИ-TrkB | |
| CY1118829T1 (el) | Ανασταλτικος vegf σταθερων και διαλυτων αντισωματων | |
| JP2017505622A5 (https=) | ||
| EA201692192A1 (ru) | СВЯЗЫВАЮЩЕЕСЯ С FcRn АНТИТЕЛО ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ ЗАБОЛЕВАНИЙ | |
| JP2016516400A5 (https=) | ||
| JP2016536330A5 (https=) | ||
| JP2017532005A5 (https=) | ||
| JP2012019790A5 (https=) | ||
| JP2021511830A5 (https=) | ||
| IL186948A0 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
| JP2014113150A5 (https=) | ||
| EA201270491A1 (ru) | Антитела, специфически связывающие рецептор ерна2 | |
| JP2015531768A5 (https=) | ||
| JP2017512838A5 (https=) |